RECURRENT MALIGNANT MESOTHELIOMA

Clinical trials for RECURRENT MALIGNANT MESOTHELIOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT MALIGNANT MESOTHELIOMA trials appear

Sign up with your email to follow new studies for RECURRENT MALIGNANT MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Terminated 1

New hope for Tough-to-Treat lung cancer? trial tests adding a Tumor-Starving drug

Disease control Ongoing

This study tested if adding a new drug called cediranib to standard chemotherapy (cisplatin and pemetrexed) works better for people with malignant pleural mesothelioma, a serious cancer often linked to asbestos. The trial had two parts: first to find a safe dose of cediranib, the…

Matched conditions: RECURRENT MALIGNANT MESOTHELIOMA

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

RECURRENT MALIGNANT MESOTHELIOMA

Get alerted when new RECURRENT MALIGNANT MESOTHELIOMA trials appear

New hope for Tough-to-Treat lung cancer? trial tests adding a Tumor-Starving drug